What is Zacks Research’s Estimate for UNH FY2024 Earnings?

UnitedHealth Group Incorporated (NYSE:UNH) – Investment analysts at Zacks Research decreased their FY2024 earnings per share estimates for shares of UnitedHealth Group in a report issued on Wednesday, November 13th. Zacks Research analyst D. Chatterjee now forecasts that the healthcare conglomerate will post earnings per share of $27.54 for the year, down from their previous estimate of $27.61. The consensus estimate for UnitedHealth Group’s current full-year earnings is $27.61 per share. Zacks Research also issued estimates for UnitedHealth Group’s Q3 2025 earnings at $7.93 EPS, FY2025 earnings at $30.11 EPS, Q2 2026 earnings at $8.09 EPS and FY2026 earnings at $34.03 EPS.

A number of other equities research analysts have also recently issued reports on the company. TD Cowen boosted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Morgan Stanley reduced their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Truist Financial reaffirmed a “buy” rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Tuesday. Finally, UBS Group cut their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Trading Down 2.1 %

NYSE UNH opened at $593.30 on Friday. UnitedHealth Group has a one year low of $436.38 and a one year high of $630.73. The business’s fifty day moving average is $582.99 and its 200-day moving average is $548.03. The stock has a market capitalization of $546.00 billion, a price-to-earnings ratio of 38.65, a PEG ratio of 1.78 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period last year, the business earned $6.56 EPS. The business’s revenue was up 9.2% on a year-over-year basis.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. International Assets Investment Management LLC raised its stake in UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after buying an additional 5,290,025 shares during the last quarter. Swedbank AB bought a new stake in shares of UnitedHealth Group in the first quarter worth $1,117,462,000. Lone Pine Capital LLC bought a new stake in shares of UnitedHealth Group in the second quarter worth $480,903,000. Dimensional Fund Advisors LP grew its holdings in shares of UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after acquiring an additional 880,183 shares during the period. Finally, Baillie Gifford & Co. grew its holdings in shares of UnitedHealth Group by 1,125.4% in the second quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock worth $455,281,000 after acquiring an additional 821,050 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s payout ratio is presently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.